Xu, Rong <br/><br/>
Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 2009 
 - 5055-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00728-09  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Area Under Curve<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Half-Life<br/>Hantaan virus--immunology<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Mice<br/>Young Adult